- Home
- PRZO vs XCUR Comparison
PRZO vs XCUR Comparison
Compare PRZO & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRZO
- XCUR
- Stock Information
- Founded
- PRZO 2014
- XCUR 2011
- Country
- PRZO Israel
- XCUR United States
- Employees
- PRZO N/A
- XCUR N/A
- Industry
- PRZO
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- PRZO
- XCUR Health Care
- Exchange
- PRZO Nasdaq
- XCUR Nasdaq
- Market Cap
- PRZO 32.3M
- XCUR 32.4M
- IPO Year
- PRZO 2023
- XCUR N/A
- Fundamental
- Price
- PRZO $1.73
- XCUR $4.23
- Analyst Decision
- PRZO
- XCUR
- Analyst Count
- PRZO 0
- XCUR 0
- Target Price
- PRZO N/A
- XCUR N/A
- AVG Volume (30 Days)
- PRZO 1.2M
- XCUR 30.7K
- Earning Date
- PRZO 08-28-2025
- XCUR 11-13-2025
- Dividend Yield
- PRZO N/A
- XCUR N/A
- EPS Growth
- PRZO N/A
- XCUR N/A
- EPS
- PRZO N/A
- XCUR N/A
- Revenue
- PRZO $1,007,440.00
- XCUR N/A
- Revenue This Year
- PRZO N/A
- XCUR N/A
- Revenue Next Year
- PRZO N/A
- XCUR N/A
- P/E Ratio
- PRZO N/A
- XCUR N/A
- Revenue Growth
- PRZO 80.42
- XCUR N/A
- 52 Week Low
- PRZO $0.53
- XCUR $2.15
- 52 Week High
- PRZO $3.16
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- PRZO 56.56
- XCUR 44.40
- Support Level
- PRZO $1.48
- XCUR $4.12
- Resistance Level
- PRZO $1.90
- XCUR $4.57
- Average True Range (ATR)
- PRZO 0.11
- XCUR 0.34
- MACD
- PRZO 0.02
- XCUR 0.15
- Stochastic Oscillator
- PRZO 57.16
- XCUR 70.56
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.